Mid Atlantic Financial Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,590
| Closed | -$216K | – | 909 |
|
|
2021
Q2 | $216K | Sell |
2,590
-147
| -5% | -$12.3K | 0.01% | 808 |
|
|
2021
Q1 | $207K | Buy |
2,737
+19
| +0.7% | +$1.44K | 0.02% | 761 |
|
|
2020
Q4 | $238K | Sell |
2,718
-153
| -5% | -$13.4K | 0.02% | 661 |
|
|
2020
Q3 | $216K | Sell |
2,871
-62
| -2% | -$4.67K | 0.02% | 629 |
|
|
2020
Q2 | $362K | Hold |
2,933
| – | – | 0.03% | 428 |
|
|
2020
Q1 | $248K | Buy |
2,933
+64
| +2% | +$5.41K | 0.03% | 503 |
|
|
2019
Q4 | $243K | Buy |
+2,869
| New | +$243K | 0.02% | 587 |
|
|
2019
Q3 | – | Sell |
-2,433
| Closed | -$208K | – | 701 |
|
|
2019
Q2 | $208K | Sell |
2,433
-24
| -1% | -$2.05K | 0.02% | 631 |
|
|
2019
Q1 | $218K | Sell |
2,457
-118
| -5% | -$10.5K | 0.02% | 605 |
|
|
2018
Q4 | $219K | Buy |
+2,575
| New | +$219K | 0.03% | 560 |
|